CAHABA PHARMACEUTICALS
Cahaba Pharmaceuticals, LLC, a biotech company, focuses on the development of oncology therapeutics and supportive care products for cancer patients. Its products include 1uracil topical ointment, a dihydropyrimidine dehydrogenase inhibitor for the treatment of hand-foot syndrome; and triciribine phosphate monohydrate, a nucleoside analog inhibition of AKT, a key component of a signaling pathway to promote cancer cell growth and survival, and resistance to chemotherapy and radiotherapy. The company was founded in 2008 and is based in Princeton, New Jersey.
CAHABA PHARMACEUTICALS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2008-01-01
Address:
Princeton, New Jersey, United States
Country:
United States
Website Url:
http://www.cahabapharma.com
Total Employee:
1+
Status:
Closed
Contact:
609-524-2288
Total Funding:
1.79 M USD
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Aluda Pharmaceuticals
Aluda Pharmaceuticals discovers and develops innovative therapeutics broadly applicable to autoimmune diseases and cancer.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
AtlasMedx
AtlasMedx develops targeted small molecule drugs to improve the health of cancer patients.
Captain T Cell
Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients.
Cure Life Pharmaceuticals
Curelife Pharmaceuticals is a worldwide Nutraceutical Products Manufacturers.
Envara Health
Envara Health develops clinically proven, medically innovative products that enable better outcomes.
First Care Products
Developing and marketing of new products for pre-hospital emergency medical situations.
GW Pharma
GW Pharma focuses on development and commercialization in the spiritual field(CNS)Innovative drugs for indications.
KSL Biomedical
KSL Biomedical is a developers of novel companion diagnostic and therapeutic applications for immunology and oncology.
Lutris Pharma
Lutris Pharma develops drugs to improve anti-cancer therapy effectiveness.
MTrap
MTrap is developing novel therapeutic devices as a new disruptive approach to cáncer treatment.
OncoStemyx
OncoStemyx is the developer of chemotherapeutics for diagnosing cancer patients.
OncoZenge
OncoZenge develops better products for the supportive care of cancer patients.
OPUS
OPUS develops clinically applicable tissue engineering products and treatments.
Rancho Santa Fe Bio
Rancho Santa Fe Bio develops cardiovascular drugs to slow the progression of calcification in patients with aortic valve stenosis.
SarcoMed
SarcoMed develops therapeutic solutions for treating chronic pulmonary inflammation.
TheraVida
TheraVida develops and markets therapeutic products for urological disorders.
Transcend Therapeutics
Transcend Therapeutics offers novel pharmaceuticals for the critical care market.
Validus Pharmaceuticals
Validus Pharmaceuticals LLC engages in acquiring, reformulating, and marketing prescription products in specialty therapeutic areas.
VESSL Therapeutics
VESSL Therapeutics develops therapeutic modalities for cardiovascular medicine based on gene and cell therapies.
Vigeo Therapeutics
Vigeo Therapeutics is a biopharmaceutical company developing novel therapeutic agents intended to treat advanced malignant tumors.
Current Employees Featured
